Gujarat Alkalies Reports Rs 20.84 Crore PAT; Announces Rs 17.70 Dividend

Revenue grew 7% to Rs 4,358.07 crore; EBITDA rose 15.31% to Rs 521.83 crore.

Reader Takeaway: Growth strategy targets Rs 10,000 crore revenue by FY31, though import dumping remains a pricing pressure point.

What just happened

Gujarat Alkalies and Chemicals Ltd (GACL) has scheduled its Annual General Meeting for September 25, 2026. The board has recommended a dividend of Rs 17.70 per equity share. The company also unveiled 'Project Ahvaan,' a strategic roadmap aimed at achieving over Rs 10,000 crore in revenue and EBITDA margins exceeding 20% by FY31.

Why this matters

The company is aggressively pivoting toward long-term sustainability through renewable energy, which now constitutes 35.7% of its total power mix. By investing in high-margin capacities like the newly commissioned 30 KTPA Chlorotoluene plant, GACL is attempting to buffer itself against the volatility of traditional commodity chemical pricing.

Business and Operational Updates

GACL continues to focus on operational efficiency to mitigate high fuel costs. New capacity additions, including a 33,870 TPA Food Grade Phosphoric Acid facility and a 5,000 TPA High Purity Hydrogen Peroxide plant, are currently in the pipeline. These additions are intended to diversify the product mix beyond standard caustic soda.

Risks to watch

The company faces significant external pressure from cheap chemical imports, which are impacting realization rates. Furthermore, CARE Ratings recently downgraded the company's long-term debt facilities to AA-. Debt has also seen a marginal rise to Rs 567.63 crore. Investors should also monitor the ongoing litigation with the Delhi Jal Board, currently at the NCLAT stage.

What to track next

The market will look for the successful execution of 'Project Ahvaan' and the impact of the proposed Rs 1,000 crore related party transactions with GNAL and NALCO during FY 2026-27.